VivaVision Biotech, Inc
8 clinical trials · Sponsor
◉ Watch VivaVision Biotech, Inc
| Record | Firm | Date |
|---|---|---|
| A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray (NCT07259538) | VivaVision Biotech, Inc | 2025-11-06 |
| A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis (NCT07136805) | VivaVision Biotech, Inc | 2025-10-01 |
| Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease (NCT06360133) | VivaVision Biotech, Inc | 2024-04-01 |
| Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery (NCT06164743) | VivaVision Biotech, Inc | 2024-01-11 |
| Pharmacokinetics of VVN461 Ophthalmic Solution (NCT06906198) | VivaVision Biotech, Inc | 2023-03-01 |
| A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure (NCT05451329) | VivaVision Biotech, Inc | 2022-07-12 |
| Study of VVN001 Ophthalmic Solution in Dry Eye Disease (NCT04556838) | VivaVision Biotech, Inc | 2020-12-03 |
Track VivaVision Biotech, Inc automatically
Every clearance here is in the API, with alerts when new ones post.